127 results
Page 4 of 7
424B5
jedy7nmh
12 Feb 20
Prospectus supplement for primary offering
9:05am
8-K
EX-99.1
u9zar07u98yqwo83gv6w
7 Feb 20
Regulation FD Disclosure
4:46pm
8-K
EX-99.1
3yolhu19sm8wta
3 Dec 19
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
jv6r1pxvs fkdhejbeu
23 Oct 19
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit
4:29pm
8-K
EX-99.1
kqvgsu8
16 Oct 19
Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431’s Potential as a Treatment for Chronic Liver Diseases
4:54pm
8-K
lxyhf30
16 Oct 19
Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431’s Potential as a Treatment for Chronic Liver Diseases
4:54pm
8-K
EX-99.1
dspb 2zbkfof3h7yyb8
10 Oct 19
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director
11:33am
8-K
EX-99.1
6p6adkn96j3sztuot9m
3 Oct 19
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions
4:20pm
8-K
EX-99.1
b7z4bya6078
4 Sep 19
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference
11:46am
8-K
EX-99.1
751z2rz1ijf08 h55u
3 Sep 19
Other Events
4:39pm
8-K
EX-99.1
v5w4a5oxp
14 Aug 19
Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431
12:00am
8-K
EX-99.1
i142ho1yq1sp7yq5wx
7 Aug 19
Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory Board
1:11pm
8-K
EX-99.1
kb33euv
31 Jul 19
Other Events
1:41pm
8-K
EX-99.1
7a7pl1z
30 Jul 19
Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASH
4:49pm
8-K
EX-99.1
blvoo1usc oeb75jagv
23 Jul 19
Amendments to Articles of Incorporation or Bylaws
8:00am
8-K
EX-99.1
1ejcuvi372
20 Jun 19
ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering
4:30pm
424B4
eq2dyg8jfdfn6
19 Jun 19
Prospectus supplement with pricing info
5:25pm
8-K
EX-99.1
sfx7z 0dn8
17 Jun 19
Compelling Positive Results Reported from Human Liver Experiments with ContraVir Pharmaceuticals’ NASH Drug Candidate
11:18am
8-K/A
EX-99.1
c6nkd3l
12 Jun 19
Other Events
10:56am